C
cbdMD, Inc. (YCBD)
ASE – Real Time Price. Currency in USD
0.78
-0.02 (-2.97%)
At close: May 12, 2026, 3:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.78
-0.02 (-2.97%)
At close: May 12, 2026, 3:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.94 | 2.52 | 10 | |
| Quick ratio | 1.81 | 1.78 | 9.0 | |
| Debt to Equity | 0.07 | -0.80 | 9.0 | |
| Debt to Assets | 0.05 | 0.73 | 9.0 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 35M | 24M | 19M | 19M | 19M |
| Gross Profit | 21M | 13M | 11M | 11M | 10M |
| Operating Income | -17M | -9M | -3M | -2M | -2M |
| Net Income | -70M | -23M | -4M | -2M | -2M |
| EBITDA | -14M | -6M | -1M | -367K | -489K |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 11.42 | 97.37 | 8.5 |
| Next quarter | 16.94 | 80.95 | 9.5 |
| Current year | 10.49 | 87.16 | 8.5 |
| Next year | 7 | 50 | 7.5 |
| Weighted average score | 8.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.27 | 58.36 | -101.43 | -301.25 | 4.3 |
| Y/Y | -1.88 | -1975.65 | 97.73 | -102.6 | 3.3 |
| 3y average | -17.52 | 65.33 | 85.03 | -2.37 | 5.5 |
| 5y average | -13.35 | -57.83 | -35.31 | -9.71 | 1.0 |
| Weighted average score | 3.5 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $3.4M significantly exceed its total debt $593.0K, ensuring strong financial flexibility
Total current assets $8.2M exceed Total current liabilities $2.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$977.3K limits the company's ability to reinvest or pay down debt